A detailed history of Larson Financial Group LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Larson Financial Group LLC holds 1,110 shares of IONS stock, worth $79,420. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,110
Previous 1,027 8.08%
Holding current value
$79,420
Previous $40,000 80.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$39.94 - $65.42 $3,315 - $5,429
83 Added 8.08%
1,110 $72,000
Q2 2025

Aug 08, 2025

BUY
$25.51 - $40.0 $17,448 - $27,360
684 Added 199.42%
1,027 $40,000
Q1 2025

May 02, 2025

BUY
$30.17 - $34.97 $9,805 - $11,365
325 Added 1805.56%
343 $10,000
Q2 2024

Aug 02, 2024

BUY
$36.45 - $47.7 $656 - $858
18 New
18 $0

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $10.2B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Larson Financial Group LLC Portfolio

Follow Larson Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Larson Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Larson Financial Group LLC with notifications on news.